Publicaciones en colaboración con investigadores/as de Universitat de Barcelona (19)

2022

  1. Multicentre study on the reproducibility of MALDI-TOF MS for nontuberculous mycobacteria identification

    Scientific Reports, Vol. 12, Núm. 1

2020

  1. Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 4, pp. 182-187

2019

  1. Multiplex real-time PCR-shortTUB assay for detection of the mycobacterium tuberculosis complex in smear-negative clinical samples with low mycobacterial loads

    Journal of Clinical Microbiology, Vol. 57, Núm. 8

2018

  1. How to: identify non-tuberculous Mycobacterium species using MALDI-TOF mass spectrometry

    Clinical Microbiology and Infection, Vol. 24, Núm. 6, pp. 599-603

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

  3. The outer membrane porin OmpW of Acinetobacter baumannii is involved in iron uptake and colistin binding

    FEBS Letters, Vol. 590, Núm. 2, pp. 224-231

2015

  1. Reduced susceptibility to biocides in Acinetobacter baumannii: Association with resistance to antimicrobials, epidemiological behaviour, biological cost and effect on the expression of genes encoding porins and efflux pumps

    Journal of Antimicrobial Chemotherapy, Vol. 70, Núm. 12, pp. 3222-3229

2014

  1. Characterization of plasmids carrying the blaOXA-24/40 carbapenemase gene and the genes encoding the AbkA/AbkB proteins of a toxin/antitoxin system

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 10, pp. 2629-2633

  2. Detection of carbapenemase-producing Enterobacteriaceae in various scenarios and health settings

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 32, Núm. S4, pp. 24-32

2013

  1. Actividad de 18 agentes antimicrobianos frente a aislados clínicos de Acinetobacter baumannii: segundo estudio nacional multicéntrico (proyecto GEIH-REIPI-Ab 2010)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 31, Núm. 1, pp. 4-9

  2. Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii

    Antimicrobial Agents and Chemotherapy, Vol. 57, Núm. 11, pp. 5247-5257

  3. Erratum: Actividad de 18 agentes antimicrobianos frente a aislados clínicos de Acinetobacter baumannii: Segundo estudio nacional multicéntrico (proyecto GEIH-REIPI-Ab 2010) (Enfermedades Infecciosas y Microbiologia Clinica (2013) 31 (4-9))

    Enfermedades Infecciosas y Microbiologia Clinica

  4. First report of an OXA-23 carbapenemase-producing Acinetobacter baumannii clinical isolate related to Tn2006 in Spain

    Antimicrobial Agents and Chemotherapy, Vol. 57, Núm. 1, pp. 589-591

2012

  1. Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort

    Transplant Infectious Disease, Vol. 14, Núm. 6, pp. 595-603

  2. Multidrug-resistant bacterial infection in solid organ transplant recipients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 30, Núm. SUPPL.2, pp. 40-48

  3. Prevalence and analysis of microbiological factors associated with phenotypic heterogeneous resistance to carbapenems in Acinetobacter baumannii

    International Journal of Antimicrobial Agents

2008

  1. Impact of current transplantation management on the development of cytomegalovirus disease after renal transplantation

    Clinical Infectious Diseases, Vol. 47, Núm. 7, pp. 875-882

2004

  1. Antimicrobial Susceptibility and Mechanisms of Resistance to Quinolones and β-Lactams in Acinetobacter Genospecies 3

    Antimicrobial Agents and Chemotherapy, Vol. 48, Núm. 4, pp. 1430-1432